IP Library › Granted Patent US 12,217,384
Granted Patent B2
US 12,217,384 · App. 17/795,279 · Granted Feb 4, 2025

Contrast enhancement method for the objects with intrinsic partial volume effect

Inventors: Jinghua Wang (Mason, OH); Lili He (Mason, OH)
Assignees: University of Cincinnati; Children's Hospital Medical Center
G06T3/40G06T5/94G06T7/0012A61B6/481A61B8/481G06T2207/10088G06T2207/30096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,217,384
App. No.
17/795,279
Granted
Feb 4, 2025
Kind
B2
Abstract

A method for spatial resolution enhanced imaging is provided. The method includes determining a target region of a subject being imaged; estimating an achievable spatial resolution; selecting an increased spatial resolution that is greater than a predetermined spatial resolution and equal to or less than the achievable spatial resolution; and acquiring image data of the target region with the increased spatial resolution. A method for enhancing the contrast between the region of interest and other tissue region in the image data acquired with the increased spatial resolution and other tissue region in image data acquired with the predetermined spatial resolution due to the intrinsic partial volume effect is also provided.

Claims (35)

1. A method for spatial resolution enhanced imaging, the method comprising:

determining a target region of a subject being imaged;

estimating an achievable spatial resolution;

selecting an increased spatial resolution that is greater than a predetermined spatial resolution and equal to or less than the achievable spatial resolution; and

acquiring image data of the target region with the increased spatial resolution, wherein a voxel or a pixel of the image data corresponding to a region of interest in the target region includes intrinsic partial volume effect and another voxel or pixel of the image data corresponding to a boundary of the region of interest in the target region includes extrinsic partial volume effect,

wherein a contrast between the region of interest and other tissue region in the image data acquired with the increased spatial resolution is greater than a contrast between the region of interest and other tissue region in the image data acquired with the predetermined spatial resolution due to the intrinsic partial volume effect.

2. The method of claim 1 , wherein the voxel or pixel of the image data corresponding to the region of interest further comprises cells and molecules with the different pathological or physiological features that are characterized by radiomic features derived from the radiological images.

3. The method of claim 1 , further comprising:

administering contrast agent,

wherein the intrinsic partial volume effect consists of a cell with contrast agent leakage and a cell without contrast agent leakage.

4. The method of claim 1 , wherein the intrinsic partial volume effect consists of a lesion cell and a non-lesion cell.

5. The method of claim 1 , wherein the image data is acquired with functional imaging; and

the intrinsic partial volume effect consists of excited neurons and non-excited neurons.

6. The method of claim 1 , wherein the image data of the subject is received from one of, X-ray, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), magnetic resonance spectroscopy imaging (MRSI), positron emission tomography (PET), near-infrared (NIR) fluorescence imaging, nuclear medicine imaging, and their variations.

7. The method of claim 1 , wherein the increased spatial resolution is greater than a half of the achievable spatial resolution.

8. The method of claim 1 , wherein the increased spatial resolution is between a half of the achievable spatial resolution and two thirds of the achievable spatial resolution.

9. The method of claim 1 , wherein the increased spatial resolution is between two thirds of the achievable spatial resolution and the achievable spatial resolution.

10. The method of claim 7 , wherein the achievable spatial resolution is determined by various factors including imaging modalities, hardware, imaging parameters, acquisition time, and image reconstruction.

11. The method of claim 7 , further comprising implementing one of lesion detection, disease diagnosis, treatment planning and treatment assessment based on the acquired image data.

12. The method of claim 1 , wherein the predetermined spatial resolution is a spatial resolution used in clinical or research practice.

13. A system for contrast enhancement, the system comprising:

a processor configured to:

determine a target region of a subject being imaged;

estimate an achievable spatial resolution; and

select an increased spatial resolution that is greater than a predetermined spatial resolution and equal to or less than the achievable spatial resolution; and

a receiver configured to acquire image data of the target region with the increased spatial resolution, wherein a voxel or a pixel of the image data corresponding to a region of interest in the target region includes intrinsic partial volume effect and another voxel or pixel of the image data corresponding to a boundary of the region of interest in the target region includes extrinsic partial volume effect,

wherein a contrast between the region of interest and other tissue region in the image data acquired with the increased spatial resolution is greater than a contrast between the region of interest and other tissue region in image data acquired with the predetermined spatial resolution due to the intrinsic partial volume effect.

14. The system of claim 13 , wherein the voxel or pixel of the image data corresponding to the region of interest further comprises cells and molecules with the different pathological or physiological features that are characterized by radiomic features derived from the radiological images.

15. The system of claim 13 , wherein the intrinsic partial volume effect includes a cell with contrast agent leakage and a cell without contrast agent leakage.

16. The system of claim 13 , wherein the image data is acquired with functional imaging; and

the intrinsic partial volume effect include excited neurons and non-excited neurons.

17. The system of claim 13 , wherein the increased spatial resolution is greater than a half of the achievable spatial resolution.

18. The system of claim 13 , wherein the increased spatial resolution is between a half of the achievable spatial resolution and two thirds of the achievable spatial resolution.

19. The system of claim 13 , wherein the increased spatial resolution is between two thirds of the achievable spatial resolution and the achievable spatial resolution.

20. The system of claim 13 , wherein the controller reduces a dose of a contrast agent to be applied to the subject when image data of the subject is acquired with the increased spatial resolution to be less than a dose of the contrast agent to be applied to the subject when image data of the subject is acquired with the predetermined spatial resolution.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2022
From: WANG, JINGHUA
To: UNIVERSITY OF CINCINNATI
Reel/Frame 060621/0064 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2022
From: HE, LILI
To: CHILDREN'S HOSPITAL MEDICAL CENTER
Reel/Frame 060621/0273 →
Continuity (2)
Provisional Application 62967207 · Jan 29, 2020
Related Publication 20230072303A1 · Mar 9, 2023
References Cited (21)
US 5768413A · Levin et al. · 1998 [cited by applicant]
US 6633684B1 · James · 2003 [cited by applicant]
US 6757442B1 · Avinash · 2004 [cited by applicant]
US 7727155B2 · de Ziegler · 2010 [cited by applicant]
US 8378134B2 · Grimmond et al. · 2013 [cited by applicant]
US 8774480B2 · Roy et al. · 2014 [cited by applicant]
US 9372245B2 · Singh et al. · 2016 [cited by applicant]
US 10055827B2 · Zhou et al. · 2018 [cited by applicant]
US 10407412B2 · Boi et al. · 2019 [cited by applicant]
US 10525152B2 · Sigalov · 2020 [cited by applicant]
US 20040004188A1 · Tai · 2004 [cited by applicant]
US 20160093023A1 · Prasad · 2016 [cited by examiner]
US 20170053414A1 · Flohr · 2017 [cited by examiner]
US 20180280544A1 · Yang et al. · 2018 [cited by applicant]
US 20190026873A1 · Luciano et al. · 2019 [cited by applicant]
US 20190056470A1 · Wang · 2019 [cited by applicant]
US 20190231288A1 · Profio · 2019 [cited by examiner]
WO 2019002560A1 · 2019 [cited by applicant]
WO WO2019157119A1 · 2019 [cited by examiner]
WO 2020072784A9 · 2020 [cited by applicant]
International Search Report and Written Opinion mailed Apr. 21, 2021 in reference to co-pending Application No. PCT/US2021/14986 filed Jan. 29, 2020. [cited by applicant]